NAGE — Niagen Bioscience Inc

🔔 Alert me if NAGE files an offering or S-3

Active shelf registration (S-3, Jun 2026). Float: 51.9M shares. Latest SEC filing: 10-Q on Aug 4, 2026. NAGE closed at $2.40 (+3.00%) on Nov 2, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for NAGE in the TickerWise workspace.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 104
• Website: https://www.niagenbioscience.com

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

Latest SEC filings for NAGE

• 2026-08-0410-Q
• 2026-08-048-K
• 2026-07-10EFFECT
• 2026-07-10424B5
• 2026-07-10424B5
• 2026-06-298-K
• 2026-06-29S-3
• 2026-05-068-K
• 2026-05-0610-Q
• 2026-03-198-K

Latest NAGE news

• 2026-11-03Niagen Bioscience Q3 2026 Earnings Preview Read article
• 2026-10-28Earnings Preview: Niagen Bioscience (NAGE) Q3 Earnings Expected to Decline Read article
• 2026-10-06Niagen Bioscience to Present at LD Micro 20th Annual Main Event Read article

Related companies

• VRTX — Vertex Pharmaceuticals Incorporated
• MRNA — Moderna, Inc.
• REGN — Regeneron Pharmaceuticals, Inc.
• ARGX — argenx SE
• ALNY — Alnylam Pharmaceuticals, Inc.
• INSM — Insmed Incorporated
• RVMD — Revolution Medicines, Inc.
• UTHR — United Therapeutics Corporation

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.